Literature DB >> 8045487

Molecular species of hepadnavirus core and envelope polypeptides in hepatocyte plasma membrane of woodchucks with acute and chronic viral hepatitis.

T I Michalak1, B Lin.   

Abstract

Hepadnaviral antigens exposed on hepatocytes serve as targets and as possible modulators of immunopathogenic reactions causing liver damage. To identify molecular species of viral proteins at the liver cell surface and the relationship between their expression and the persistence and severity of virus-induced liver injury, we examined woodchuck hepatitis virus core and envelope polypeptides in host hepatocyte plasma membranes from acute and chronic hepatitis. Western blot analysis revealed that two virus core polypeptides with a molecular mass of 22 kD and 43 kD occur in the membranes of infected animals. The molecular profiles and the membrane levels of the core antigen were not related to the duration or histological severity of liver damage. In contrast, quantities of the virus surface antigen were significantly greater in hepatocyte membranes of animals with chronic hepatitis. The envelope preS1, preS2 and S polypeptides, with or without molecular mass equivalents in the subviral surface antigen particles and virions, were detected in all infected membranes, although the preS2 polypeptides were always dominant. Our findings indicate that hepadnavirus core and envelope polypeptides are integral constituents of hepatocyte membranes in the course of hepatitis. They demonstrate that the accumulation of viral envelope proteins, predominantly the S-domain sequences, in hepatocyte membranes is a prominent characteristic of chronic hepatitis. This event might contribute to promotion of development and maintenance of hepadnavirus-related chronic liver disease.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8045487

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  11 in total

1.  Profound antiviral effect of oral administration of MIV-210 on chronic hepadnaviral infection in a woodchuck model of hepatitis B.

Authors:  Tomasz I Michalak; Hong Zhang; Norma D Churchill; Torbjörn Larsson; Nils-Gunnar Johansson; Bo Oberg
Journal:  Antimicrob Agents Chemother       Date:  2009-06-29       Impact factor: 5.191

2.  Posttranscriptional inhibition of class I major histocompatibility complex presentation on hepatocytes and lymphoid cells in chronic woodchuck hepatitis virus infection.

Authors:  T I Michalak; P D Hodgson; N D Churchill
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

3.  Inhibition by woodchuck hepatitis virus of class I major histocompatibility complex presentation on hepatocytes is mediated by virus envelope pre-S2 protein and can be reversed by treatment with gamma interferon.

Authors:  Jinguo Wang; Tomasz I Michalak
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

4.  Perforin and Fas/Fas ligand-mediated cytotoxicity in acute and chronic woodchuck viral hepatitis.

Authors:  P D Hodgson; M D Grant; T I Michalak
Journal:  Clin Exp Immunol       Date:  1999-10       Impact factor: 4.330

5.  Persistence of infectious hepadnavirus in the offspring of woodchuck mothers recovered from viral hepatitis.

Authors:  C S Coffin; T I Michalak
Journal:  J Clin Invest       Date:  1999-07       Impact factor: 14.808

6.  Pathomorphological Characteristics and Pathogenesis of Viral Hepatitis.

Authors:  Zsuzsa Schaff; Gábor Lotz; Rolf Schulte-Herman
Journal:  Pathol Oncol Res       Date:  1996       Impact factor: 3.201

7.  In vitro and in vivo infectivity and pathogenicity of the lymphoid cell-derived woodchuck hepatitis virus.

Authors:  Y Y Lew; T I Michalak
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

8.  Intrahepatic expression of genes affiliated with innate and adaptive immune responses immediately after invasion and during acute infection with woodchuck hepadnavirus.

Authors:  Clifford S Guy; Patricia M Mulrooney-Cousins; Norma D Churchill; Tomasz I Michalak
Journal:  J Virol       Date:  2008-07-02       Impact factor: 5.103

9.  Low doses of hepadnavirus induce infection of the lymphatic system that does not engage the liver.

Authors:  Tomasz I Michalak; Patricia M Mulrooney; Carla S Coffin
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

10.  Antibody-directed complement-mediated cytotoxicity to hepatocytes from patients with chronic hepatitis B.

Authors:  T I Michalak; J Y Lau; B M McFarlane; G J Alexander; A L Eddleston; R Williams
Journal:  Clin Exp Immunol       Date:  1995-05       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.